Gambia Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials
• Forums

Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination
Condition:   Malaria Interventions:   Drug: dihydroartemisinin-piperaquine (DP);   Drug: ivermectin (IVM);   Other: standard malaria control interventions only Sponsors:   London School of Hygiene and Tropical Medicine;   Institute of Tropical Medicine, Belgium;   National Malaria Control Programme, The Gambia;   Liverpool School of Tropical Medicine;   Radboud University;   University of Durham;   Imperial College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2018 Category: Research Source Type: clinical trials